UBIC CONSULTING 2 0 1 5 Marketing development Strategy - - PowerPoint PPT Presentation

ubic
SMART_READER_LITE
LIVE PREVIEW

UBIC CONSULTING 2 0 1 5 Marketing development Strategy - - PowerPoint PPT Presentation

THE WORLD LACTOFERRIN AND LACTOPEROXIDASE MARKET Science Market Regulation UBIC CONSULTING 2 0 1 5 Marketing development Strategy consulting Partnership searches Information systems 350 pages SCIENCE MARKET REGULATION -


slide-1
SLIDE 1

UBIC

CONSULTING

Science Market Regulation

Marketing development Strategy consulting Partnership searches Information systems

THE WORLD LACTOFERRIN AND LACTOPEROXIDASE MARKET

2 0 1 5

slide-2
SLIDE 2

350 pages

This comprehensive report is based on in-depth interviews with food companies completed by a desk review. It provides for DECISION MAKERS a global understanding of the sector as well as an outlook on its future.

SCIENCE – MARKET – REGULATION - MANUFATURERS

New trends and perspectives Use of ingredients: volumes-value Manufacturers profiles User’s opinion Regulation North America Western and Eastern Europe Asia Australia- New Zealand Food industry Cosmetics Pharmacy Industrial markets Lactoferrin Lactoperoxidase

MARKET ANALYSIS INGREDIENTS FOOD SEGMENTS COUNTRIES COVERED

slide-3
SLIDE 3

350 pages

O B J E C T I V E S M A R K E T

Industrial users needs, expectations and volumes Applications in segments and consumption trends Consumer market trends by food segments Prospective and forecast

M A N U F A T U R E R S

Processes and capacities Market share Company description

R E S E A R C H

New researches and developments New applications

SCIENCE – MARKET – REGULATION - MANUFATURERS

slide-4
SLIDE 4

O B J E C T I V E S M A R K E T

Industrial users needs, expectations and volumes Applications in segments and consumption trends Consumer market trends by food segments Prospective and forecast

M A N U F A T U R E R S

Processes and capacities Market share Company description

R E S E A R C H

New researches and developments New applications

It is now over 40 years since lactoferrin was first isolated. Lactoferrin, which belongs to the transferring family of proteins, is a 70-80 kDa single sub-unit glycoprotein and consist of two domains, each with one iron-binding site that requires synergistic binding

  • f

a bicarbonate

  • anion. A conformational change in the binding

site, between open or closed forms, accompanies iron binding and release. The affinity

  • f

lactoferrin for iron is much greater than

  • f

transferrin which functions as an iron carrier in

  • serum. In the “natural state”, lactoferrin is only

partly saturated with iron (5-30%) and has a salmon color, the intensity of which depends on the degree of iron saturation. It is present in human milk, and many exocrine fluids (saliva, mucous secretion) as well as mammalian.

INTRODUCTION

THE WORLD LACTOFERRIN AND LACTOPEROXIDASE MARKET

Lactoferrin concentration in different sources Bovine milk 200 mg/l Bovine colostrum 1g/l Human milk 2-4 g/l Human colostrum 6-8 g/l

Bovine LF and human LF have approximately 69%

  • f

similarities in amino acid residues. Human milk is the most abundant source of LF. It is one of the major whey proteins in human milk with concentrations of 1.4–2.0 mg mL-1 but only a minor component in bovine milk with only one tenth (0.1–0.2 mg mL-1) of concentration found in human milk. Lactoperoxidase is a hemoprotein that catalyzes the oxidation of thyocyanate and iodide ions in the presence of hydrogen peroxide to produce highly reactive oxidizing agents. These products have a broad spectrum of antimicrobial

  • effects. They can kill viruses, gram positive and

gram negative bacteria, fungi, and probably also mycoplasmas and parasites. This enzyme is primarily found in such exocrine secretions as saliva, lachrymal fluid and milk, cervical mucous and nasal glands. Human milk does not appear to contain lactoperoxidase (Tenovuo, 1985). However, a more recent study confirmed the presence

  • f lactoperoxidase in

human colostrum. In milk, lactoperoxidase is

  • ne
  • f

the non immunoglobulin protective proteins and its antibacterial activity in raw milk was suggested as early as 1924. Bovine milk contains about 20 times higher LP than that

  • f

human milk (Gothefors and Marklund 1975) and it is the second most abundant enzyme (De Wit and Van Hooydonk 1996) in bovine milk.

slide-5
SLIDE 5

Milk Water Minerals Lactose Proteins Whey Whey Protein Concentrate Immunoglobulin Alpha-Lactalbumine Beta - Lactalglobuline Bovine Serum Albumin

Lactoferrin Lactoperoxidase

Peptides Whey Protein Isolate Delactosed & Demineralized whey Caseins

Phosphocaseinates Rennet Casein Ionic Casein Caseinates Lactic Casein O B J E C T I V E S M A R K E T

Industrial users needs, expectations and volumes Applications in segments and consumption trends Consumer market trends by food segments Prospective and forecast

M A N U F A T U R E R S

Processes and capacities Market share Company description

R E S E A R C H

New researches and developments New applications

THE WORLD LACTOFERRIN AND LACTOPEROXIDASE MARKET

slide-6
SLIDE 6

O B J E C T I V E S M A R K E T

Industrial users needs, expectations and volumes Applications in segments and consumption trends Consumer market trends by food segments Prospective and forecast

M A N U F A T U R E R S

Processes and capacities Market share Company description

R E S E A R C H

New researches and developments New applications FUNCTIONALITIES

THE WORLD LACTOFERRIN AND LACTOPEROXIDASE MARKET

In many ways, lactoferrin has been an easy protein to investigate; however, there have been difficulties understanding specific structure/function relationships, particularly as it functions in vivo; Heat stability: At low ionic strength and/or low pH, the resistance

  • f

lactoferrin to heat denaturation is good and methods for heats treatment and pasteurization have been published. Iron bioavailability: Two features

  • f

the functional properties of lactoferrin are its ability to bind iron exceptionally tightly and the coupling

  • f rigid-body domain movements to iron bindings

and release. Anticarcinogenic effect: Lactoferrin has been reported to inhibit cancer growth by inducing apoptosis and stimulating the production

  • f

critical cytokines, such as IL-18 etc. Antimicrobial agent: Its capacity to bind iron and to stay bound with iron until pH 3 interfer in the proliferation of pathogen bacteria. Antiviral agent: Recently, Antiviral activity has been described as well for herpes, cytomegalo and influenzes virus. Inflammatory and Immune response: Lactoferrin has various effects on the immune system, such as regulation

  • f

antibody production, complement activation, and natural killer cell function. Anti-oxidant effect: Lactoferrin scavenges excess iron thereby protects the host to peroxidation reactions.

  • Lactoperoxidase

can be combined to lactoferrin in protection of the mucosal surface and prevention of tooth decays. Lactoperoxidase could elicit with bacteriostatic and/or bactericidal activity

  • n

a variety

  • f

susceptible microorganisms including bacteria, fungi and viruses. The molecular mechanism (s)

  • f such inhibitory effects depend on the type of

electron donor, test media, temperature and pH and could range from

  • xidative

killing to blockage of glycolytic pathways or interference in cytopathic effects; Antibacterial Effect: Gram-negative, catalase- positive

  • rganisms,

such as pseudomonas, coliforms, salmonellae and shigellae, are not

  • nly

inhibited by the lactoperoxidase system (LPS) but also, depending

  • n

the medium conditions (pH, temperature, incubation time, and cell density) may be killed. Gram-positive, catalase negative bacteria, such as streptococci and lactobacilli are generally inhibited but not killed by the LPS. Antifungal Effect: Seifu et al. declared that LPS in goat milk inhibit growth and proliferation of many fungal species viz., Aspergillus flavus, Penicillium chrysogenum, Trichoderma spp., Alternaria spp. and Claviceps spp., Corynespora cassicola, Phytophthora meadii and Corticium salmonicolor; however, Candida albicans and Pythium spp. were not affected by the this system. Antiviral Effect: Shin et al. reported the potential

  • f
  • ral

administration

  • f

LPS to attenuate pneumonia in influenza-virus-infected mice through the suppression of infiltration of inflammatory cells in the lung.

slide-7
SLIDE 7

O B J E C T I V E S M A R K E T

Industrial users needs, expectations and volumes Applications in segments and consumption trends Consumer market trends by food segments Prospective and forecast

M A N U F A T U R E R S

Processes and capacities Market share Company description

R E S E A R C H

New researches and developments New applications

THE WORLD LACTOFERRIN AND LACTOPEROXIDASE MARKET

Based on the physiological, biological and functional properties attributed to lactoferrin and lactoperoxidase, there are a number of interesting and innovative possibilities for the application of these bio-active proteins extracted from bovine milk.

APPLICATION RANGE

Functionality Food products Infant formula Sports and functional food Pharmaceuticals Veterinary and feed specialties Personal care products Lactoferrin Iron absorption

  • Anti-

inflammatory

  • Intestinal flora

protection

  • Antibacterial
  • Immune cell

stimulation

  • Antioxidant
  • Lactoperoxidase

Antimicrobial

  • Anti-

inflammatory in guts

  • Intestinal flora

protection

  • Some of the applications are related to the

natural presence

  • f

lactoferrin and lactoperoxidase in the human secretions: milk, saliva, tears. The following table will describe the potential applications of lactoferrin and lactoperoxidase.

slide-8
SLIDE 8

O B J E C T I V E S M A R K E T

Industrial users needs, expectations and volumes Applications in segments and consumption trends Consumer market trends by food segments Prospective and forecast

M A N U F A T U R E R S

Processes and capacities Market share Company description

R E S E A R C H

New researches and developments New applications OUTLOOK OF THE MARKET

THE WORLD LACTOFERRIN AND LACTOPEROXIDASE MARKET

There is a high level of competition with certain large companies that have worked on lactoferrin and lactoperoxidase for more than 20 years.

Lactoferrin has present applications in the dietetic field (food or OTC drug) and more anecdotically oral hygiene and in animal care nutrition.

slide-9
SLIDE 9

Lactoferrin Market in tons

Segment 1997 2001 2007 2008 2011 2012 FOOD & NUTRITION

  • Infant formula
  • Food

supplements

  • Dairy products
  • Others (meat,

etc) PHARMACEUTICALS

  • Iron tablets
  • Immune system

stimulation

  • Health of

intestinal flora COSMETICs and HYGIENE

  • skin care
  • body care
  • Oral hygiene

OTHERS TOTAL

THE WORLD LACTOFERRIN AND LACTOPEROXIDASE MARKET

Lactoferrin Market Forecast in tons

Segment 2011 2012 2013 2014 2015 Infant Formula Food & Nutrition

  • Food

Supplements

  • Dairy Products
  • Others (Meat,

etc.) Pharmaceuticals Cosmetics & Hygiene Others Total

slide-10
SLIDE 10

TABLE OF CONTENT

THE WORLD LACTOFERRIN AND LACTOPEROXIDASE MARKET

Methodology 10 SUMMARY AND CONCLUSIONS 12 Highlights 12 Potential Market 13 Price 14 Competition 17 Strategy and key success factors 18 Lactoferrin and Lactoperoxidase Use: The Present Market 22 Research Trends 23 Communication towards the Consumers 24 Frequently Asked Questions by the Industrial Users 24 INTRODUCTION 30 Lactoferrin and Lactoperoxidase: Two Bioactive Milk Proteins 30 FUNCTIONALITIES 31 LACTOFERRIN 31 Heat stability 31 Iron bioavailability 31 Iron uptake from lactoferrin 32 Cell proliferation 32 Antimicrobial agent 32 Antiviral agent 33 Inflammatory and Immune response 33 Anticancer activity 33 Anti-oxidant effect 34 Interaction of Lactoferrin with other molecules 34 Receptor binding properties 34 LACTOPEROXIDASE 35 Microbiological Effect of the Lactoperoxidase 36 Application of LPS in Food Industry 37 Future Trends 38 TRENDS OF RESEARCH 39 PRODUCT POSITIONING 40 PRODUCT RANGE 40 Milk Proteins 40 Competitive Products 41 Products involved in iron and calcium transport and absorption 41 Casein phosphopeptide 41 Ovotransferrin 42 Iron salts 42 Lactoperoxidase 42 Lysozyme 42 Other natural antibacterial agents 42 APPLICATION RANGE 43 LEGAL STATUS 44 COMMUNICATION ABOUT THE PRODUCT 45 PRICE 46 SPECIFICATIONS 47 EXTRACTING LACTOFERRIN 47 FUTURE TRENDS 48 COMPETITION 49 PLAYERS AND THEIR STRATEGIES 49 Producers 49 ARMOR PROTÉINES SAS (FR) 51 AGENNIX INC (US) 52 AGRI MARK INC (US) 54 FRIESLAND CAMPINA NV (NL) 56 DSM FOOD SPECIALTIES BV (NL) 61 ERIE FOODS INT’L INC (US) / MURRAY GOULBURN CO LTD (AU) 62 FONTERRA CO-OPERATIVE GROUP LTD (NZ) 63 GLANBIA NUTRITIONALS INC (US) / GLANBIA PLC (IE) 67 INGREDIA SA – (FR) 70 MILEI GMBH (DE) 73 MORINAGA MILK INDUSTRY CO LTD (JP) 76 MURRAY GOULBURN CO-OPERATIVE CO LTD (AU) 79 PHARMING GROUP NV (NL) 81 SYNLAIT (NZ) 85 TARADON LABORATORY SPRL (BE) 88 TATUA CO-OPERATIVE DAIRY CO LTD (NZ) 91 TATURA MILK INDUSTRIES LTD (AU) 93 VENTRIA BIOSCIENCE INC (US) 95

slide-11
SLIDE 11

TABLE OF CONTENT

THE WORLD LACTOFERRIN AND LACTOPEROXIDASE MARKET

VITALUS NUTRITION INC (US) 96 WESTLAND CO-OPERATIVE DAIRY CO LTD (NZ) 98 WARRNAMBOOL CHEESE & BUTTER FACTORY CO.LTD (AUS) 101 Industrial Production and Technologies 102 Bovine lactoferrin and lactoperoxidase 102 Human Lactoferrin 106 Use of transgenic animal 106 Fermentation using the fungus Aspergillus 106 Patented Processes 107 Process cost 107 Processes description 109 PROTECTED APPLICATIONS 110 TRENDS 114 MARKET ANALYSIS 115 Lactoferrin Market 115 Leading Applications 116 Lactoferrin market by Application 119 Lactoferrin market by Region 122 Main suppliers of Lactoferrin 123 LACTOFERRIN IMPORT CHINA 127 FOOD APPLICATIONS 128 Health food: Definition and Regulation 128 General trends on the Health food markets 137 Analysis by health food segments 141 Infant Nutrition 142 Regular Nutritional Food 152 Nutritional drinks 152 Mineral fortified food 155 Functional Food 156 Food Supplements 157 Women's nutrition 161 Senior diet 161 Children diet 162 Sport nutrition 162 Weight management 164 Feed 165 Preservatives in Food Products 166 Trends on the market 166 Perspective for lactoferrin and lactoperoxidase 166 Company Advice and Profile 167 ABBOTT LABORATORIES INC (US) 167 ASHLAND INC (US) 170 AVANTE INTERNATIONAL LTD (NZ) 172 ZHEJIANG BEINGMATE SCIENTIFIC INDUSTRIAL TRADE SHARE CO LTD (CN) 174 DICOFARM SPA (IT) 177 GROUPE DANONE (NL) 178 EAGLE ELECTRIC (Shenzhen) Co., Ltd (CH) 180 GUANGDONG YASHILI GROUP CO LTD (CN) 181 HEILONGJIANG YAOLAN DAIRY PRODUCTS STOCKS Co., Ltd (CN) 183 HANS CORP CO LTD (KR) 185 HOCHDORF NUTRICARE (CH) 188 JIANGXI MEILU DAIRY CP LTD (CN) 189 ANONYOUS CORPORATION (JP) 192 WEIDER NUTRITION INTERNATIONAL INC (US) 194 MAEL DAIRY INDUSTRY (KR) 196 MEAD JOHNSON NUTRITION / MEAD JOHNSON & COMPANY LLC (US) 197 MEIJI MILK PRODUCTS CO LTD (JP) 199 MEGMILK SNOW BRAND CO LTD (JP) 201 MORINAGA MILK INDUSTRY CO LTD (JP) 205 MURRAY GOULBURN CO-OPERATIVE CO LTD (AUS) 208 NESTLÉ SA (CH) 210 NAMYANG DAIRY PRODUCTS CO LTD (KR) 212 DANONE NUTRICIA ADVANCED MEDICAL NUTRITION (NL) 213 NUTRIDAR PLC (JO) 214 SEOUL DAIRY COOPERATUVE/ SEOUL MILK CO LTD (KR) 216 OTSUKA PHARMACEUTICAL CO LTD (JP) 218 LABORATORIOS ORDESA SL (SP) 219 PT SARI HUSADA (INDONESIA) / GROUDE DANONE (FR) 222 QUAKER (US) 224 NESTLÉ PURINA PETCARE COMPANY (US) / NESTLÉ SA (CH) 226

slide-12
SLIDE 12

TABLE OF CONTENT

THE WORLD LACTOFERRIN AND LACTOPEROXIDASE MARKET

REBORNNE NEW ZEALAND LTD (NZ) 227 SCHIFF NUTRITION INTERNATIONAL INC (US) 228 SHANGAI BRIGHT (GUANGMING) DAIRY & FOOD CO LTD (CN) 229 SODIAAL SA (FR) 231 SUNTORY HOLDINGS LTD (JP) 233 UNITED DAIRY GROUP LTD (CN) 234 WAKODO CO LTD (JP) 237 INNER MONGOLIA YILI INDUSTRIAL GROUP CO LTD (CN) 238 YABAIS DAIRY PRODUCTS CO LTD (AU) 240 ZIM LABORATORIES LTD (IN) 244 PHARMACEUTICAL APPLICATIONS 245 Trends on the market 245 Pharmaceutical drugs market 245 Over the counter drugs market 245 Cosmetic market 249 Perspectives for lactoferrin and lactoperoxidase 251 Immune system support 251 Anti-infective 251 Gastro-intestinal tract 251 Ophtalmic products 252 Anti-cancer therapeutic agent 252 Product conservation 252 Skin Health 253 Anti-oxydant activity 253 Lactoferrin Contraindications, Interactions & Precautions 254 Company advices 255 ALCON LABORATORIES (NOVARTIS GROUP-FR) 255 BAUSCH & LOMB (US) 256 PFIZER (ex JOUVEINAL - FR) 257 LACLED INC (US) 258 MERCK & CO (US) 260 METAGENICS INC (US) 261 MP BIOMEDICALS (US) 263 NRL PHARMA INC (JP) 265 OENOBIOL LABORATORIES (FR) 269 PIERRE FABRE SA (FR) 270 PROHEALTH INC (CA) 271 SYMBIOTICS INC / NATURADE INC (US) 274 SOVEREIGN LABORATORIES INC (US) 275 GROUPE GTF (FR) 278 XIGO HEALTH LLC (US) 279 ZENDIUM / UNILIVER NV (NL) 280 ZIM LABORATORIES LTD (IN) 282 LOVELY HEALTH LTD (NZ) 283 FIT-BIOCEUTICALS LTD (AU) 284 VIDA NUTRISCIENCE INC (PH) 286 LIFE EXTENSION INC (US) 287 GENOSCOPE SPZOO (PL) 288 ANNEXES 289 US PATENT 290 Lactoferrin 290 Lactoperoxidase 302 REGULATION 319 CFSAN/Office of Premarket Approval 319 Data and information that DMV International presents to support its GRAS determination 319 FDA's evaluation of the data and information in DMV International's notice 320 Conclusions 321 CFSAN/Office of Food Additive Safety 322 REGULATION– NOVEL FOOD PETITION 325 SPECIFICATIONS 329 STUDIES 332 CHINESE IMPORTATIONS OF LACTOFERRIN – LIST OF USERS / JAN-DEC 2012 336

slide-13
SLIDE 13

LIST OF TABLES

THE WORLD LACTOFERRIN AND LACTOPEROXIDASE MARKET

Table 1 Lactoferrin market in tons estimations and forecast 1997-2015 12 Table 2 Consumption of Lactoferrin by market segment 13 Table 3 Lactoferrin potential market segment and main products 14 Table 4 Present market of Lactoferrin market 22 Table 5 Present market of Lactoperoxidase 23 Table 6 Potentialities of Lactoferrin in Food Products 25 Table 7 In OTC and Semi-ethical Drugs 26 Table 8 In cosmetic and oral hygiene products 27 Table 9 Potentialities of Lactoperoxidase In food products 28 Table 10 In cosmetic and oral hygiene products 29 Table 11 In OTC and semi-ethical drugs 29 Table 12 Interaction of Other Molecules and Lactoferrin 34 Table 13 Nutritional/biological function in Milk protein and Bioactive 40 Table 14 Potential Application in Lactoferrin and Lactoperoxidase 43 Table 15 Main suppliers of Lactoferrin 50 Table 16 Extraction methods performed by different companies 105 Table 17 Patented process in Lactoferrin Manufactures 107 Table 18 Patented Lactoferrin Based Products and Applications 110 Table 19 Patented Lactoperoxidase Based Products and Applications 113 Table 20 Examples of LF application available in Japan 116 Table 21 Lactoferrin market in tons estimations and forecast 1997-2015 118 Table 22 Lactoferrin market Forecast in Infant Formula 2011-2015 (tons) 119 Table 23 Lactoferrin market Forecast in Foods 2011-2015 (tons) 119 Table 24 Lactoferrin market Forecast in Pharmaceuticals 2011-2015 (tons) 120 Table 25 Lactoferrin market Forecast in Hygiene 2011-2015 (tons) 121 Table 26 Consumption of Lactoferrin by market segment (ton) – 2014 122 Table 27: Lactoferrin Import China 2012 127 Table 28 Approved FDA health claims in specific cases (food and nutrition) 135 Table 29 Nutraceuticals market in Japan (2011) 137 Table 30 Health foods Category in Japan (2011) 138 Table 31 Global users of Lactoferrin in Infant Formula (2012) 149 Table 32 Japanese users of Lactoferrin in Infant milk and formula milk (2013)151 Table 33 Comparisons of Main Nutritional Formulas 153 Table 34 Sales of Leading Functional Drinks in Japan 154 Table 35 Other using segments for Lactoferrin - Functional Food 156 Table 36 Ingredient nutrition example of Lactoferrin tablet in USA 157 Table 37 Other using segments for Lactoferrin- Food Supplements 158 Table 38 Other using segments for Lactoferrin 165 Table 39 New Food Biopreservatives 166 Table 40 OTC main categories in USA 247 Table 41 Other using segments for Lactoferrin - Cosmetic 250 Table 42 US PATENT of Lactoferrin 290 Table 43 US PATENT of Lactoperoxidase 302

slide-14
SLIDE 14

LIST OF FIGURES

THE WORLD LACTOFERRIN AND LACTOPEROXIDASE MARKET

Figure 1 Most Promising Segments of Development for Lactoferrin 16 Figure 2 the World Lactoferrin Market by Shares of Producers (2015) 17 Figure 3 Strategic Issues for Lactoferrin and Lactoperoxidase 20 Figure 4 Strategic recommendations for using Lactoferrin 21 Figure 5 Relative added value pyramid for protein derived from whey 46 Figure 6 General extraction methods of Lactoferrin and Lactoperoxidase 102 Figure 7: Lactoferrin’ global Market volume estimations (2007-2017) 115 Figure 8: Lactoferrin market breakdown by application 2014 117 Figure 9 Lactoferrin market Forecast in FOOD & NUTRITION (2015) 119 Figure 10 Lactoferrin market Forecast in Pharmaceuticals (2015) 120 Figure 11 Lactoferrin market Forecast in Pharmaceuticals (2015) 121 Figure 12: Lactoferrin market breakdown by application 2014 121 Figure 13: Lactoferrin market consumption by geographical area 2014 122 Figure 14: Lactoferrin Import in China in volume by month 2012 127 Figure 15: Country of origin of Lactoferrin imported (in kg) in China 2012 127 Figure 16: Chinese Import of Lactoferrin from the EU - 2012 128 Figure 17 Schematic Circuits for a Novel Food Dossier 130 Figure 18 Schematic Circuits for a New Additive Dossier 131 Figure 19. Health Foods without FOSHU (billion Yen) 1988-2011 137 Figure 20. Market Scale of FOSHU in Japan (billion Yen) 1997-2011 138 Figure 21. Annual trends in Number of Items of FOSHU (1993-2012) 139 Figure 22. Percentage of the Products by Health Claim FOSHU (2011) 139 Figure 23 History of Infant Formula’s product and modification 143 Figure 24: Share Individual OTC market in Europe 247 Figure 25: OTC Drug market size in Japan 2004-2013 248

slide-15
SLIDE 15

ORDER FORM

THE WORLD LACTOFERRIN AND LACTOPEROXIDASE MARKET

ORDER FORM

Study purchase includes one year update available on-line on UBIC’s Extranet Assistance is also available for specific questions

COMPANY ________________________________________________________________________ Name _________________________________ Position _________________________________ _______________________________________________________________________________ _________________________________________________________________________________ Tel.:_____________________________________ Date _____________________________________ Signature__________________________________

Sections Up-date 2015 Complete study

  • € 4.900

Executive Summary - 45 pages Market analysis Europe USA - Canada Cost by section

Study purchase includes one year update available on-line on UBIC’s Extranet Assistance is also available for specific questions

COMPANY ________________________________________________________________________ Name _________________________________ Position _________________________________ _______________________________________________________________________________ _________________________________________________________________________________ Tel.:_____________________________________ Date _____________________________________ Signature__________________________________

All Sections Executive summary

  • € 3.850
  • € 1.875
  • € 1.290
  • € 1.490
  • € 2.550

Asia - Oceania

slide-16
SLIDE 16

UBIC CONSULTING IN THE WORLD

UBIC USA UBIC EUROPE UBIC FRANCE UBIC IRELAND

www.ubic-consulting.com

UBIC USA 5020 Campus Drives NEWPORT BEACH CA-92660 Phone: 1 949 296 7544 Fax: 1 949 752 2287 info@ubicusa.com UBIC EUROPE TechnoArk 1 3960 SIERRE Switzerland Phone: +41 (0) 27 456 1440 +41 (0) 27 456 1444 Fax: +41 (0) 27 456 1447 info@ubiceurope.com UBIC IRELAND 24, Foley Street DUBLIN 1 Ireland Phone: 353 1 876 48 05 Fax: 353 1 876 48 04 info@ubiceurope.com UBIC JAPAN 5 -4-3-1015 Motomachi, Chuo-ku Kobe, 650-0022 JAPAN Phone: +81 50 3693 4318 Fax: +81 50 3488 4318 japan@ubic-consulting.com

UBIC JAPAN

Argentina Mexico

UBIC CHINA UBIC INDONESIA

Russia India

UBIC MENA UBIC BRAZIL Partners